2024. Precision Oncology Molecular Tumour Boards: Recommendation Rates, Access and Outcome Attribution. Translational Medicine & Therapeutics Journal. 3, 2 (Jul. 2024), 64–73. DOI:https://doi.org/10.5281/zenodo.22649281.